Drug Trial Radar · NCT07168902
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
Last checked: Nov 19, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
252
Actual
Start
Oct 24, 2025
Primary completion
May 18, 2026
Study completion May 18, 2026
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Sep 11, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults with Primary Open Angle Glaucoma or Ocular Hypertension
Conditions
- Glaucoma
Interventions
BL1107 Low doseDrug
Dosed twice daily for 28 days.
BL1107 High doseDrug
Dosed twice daily for 28 days.
Timolol maleate 0.5%Drug
Dosed twice daily for 28 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in visual field mean deviation in the study eye at Day 28/Exit.Time frame: Assessed at Day 28
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Global Research Management, Inc.
Glendale, California
Eye Research Foundation
Newport Beach, California
California Eye Specialist Medical Group, LLC
Pasadena, California
Eye Associates of Fort Myers
Fort Myers, Florida
Levenson Eye Associates
Jacksonville, Florida
Central Florida Eye Associates
Lakeland, Florida
Lee Shettle Eye and Hearing
Largo, Florida
Clayton Eye Clinical Research, LLC
Morrow, Georgia
Coastal Research Associates, LLC
Roswell, Georgia
Heart of America Eye Care
Shawnee Mission, Kansas
Andover Eye Associates
Andover, Massachusetts
Scott & Christie and Associates, PC
Cranberry Township, Pennsylvania
Total Eye Care, P.A.
Memphis, Tennessee
Houston Eye Associates
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.